- PLN63.86m
- PLN77.69m
- PLN95.56m
- 83
- 69
- 56
- 82
Annual balance sheet for Biogened SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | PAS | PAS | PAS | PAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.2 | 2.55 | 4.97 | 3.46 | 7.51 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 32.8 | 23.3 | 23.1 | 19.3 | 19.7 |
| Total Inventory | |||||
| Total Current Assets | 46.2 | 39.5 | 39.5 | 42.4 | 45.7 |
| Net Property, Plant And Equipment | 14.4 | 14.2 | 15.9 | 21.9 | 26.3 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 84.7 | 83.4 | 61 | 71.3 | 76.9 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22.9 | 20.4 | 23.1 | 19 | 30.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 30.7 | 28.7 | 31.1 | 38.7 | 41 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 54 | 54.7 | 29.9 | 32.6 | 35.8 |
| Total Liabilities & Shareholders' Equity | 84.7 | 83.4 | 61 | 71.3 | 76.9 |
| Total Common Shares Outstanding |